Akses terbuka
Jurnal
SINTA 1
Comparative efficacy of topical 10% versus 5% tranexamic acid in treatment of women with melasma: a double-blind randomized controlled trial
Universa Medicina · Vol. 43 No. 2 (2024) · hlm. 213–219
ISSN 2407-2230, 1907-3062
Terbit 2024-08-12
Penerbit Faculty of Medicine, Universitas Trisakti
Bahasa eng
Abstrak
BackgroundMelasma is a highly prevalent chronic pigmentary disorder. The pathogenesis is unknown but melasma often occurs in photo-exposed areas, e.g., cheeks, upper lip, chin, and forehead. Tranexamic acid (TA), a plasmin inhibitor, aids in the inhibition of UV-induced plasmin activity and melanogenesis, making it a favorable therapeutic option for melasma. Tranexamic acid may be administered through various routes, e.g., topical. This study aimed to compare the efficacy of topical 10% versus 5% TA in women with melasma. MethodsThis double-blind randomized controlled trial included 16 females with epidermal type melasma who were randomized into two groups to receive either topical 10% TA (n = 8) or 5% TA (n = 8) applied twice daily for eight weeks. Prior to intervention and at 8 weeks after intervention, the intensity and extension of melasma were assessed based on melasma area and severity index (MASI) score and pigmentation score. ResultsMean MASI and pigmentation scores in both treatment groups were similar at base-line (p>0.05). The reduction in MASI and pigmentation scores in the topical 10% TA and 5% TA groups was similar and statistically not significant after 4 and 8 weeks of treatment (p>0.05). There were no drug-related adverse reactions or complications. ConclusionThis study demonstrated that topical 10% TA and 5% TA were effective in treating women with melasma. The utilization of topical 5% TA for melasma is a promising alternative therapeutic option without the need to increase the concentration of the formulation.
Jaringan kolaborasi para penulis
9 penulis ·
27 tautan kepenulisan bersama
Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.
Sam Ratulangi University Afiliasi tidak diketahui
Organisasi berbeda
Organisasi sama
Afiliasi tidak diketahui
Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.
Sumber metadata: OAI-PMH (metadata jurnal) https://univmed.org/ejurnal/index.php/medicina/oai, pertama di-harvest 10 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title xml:lang="en">Comparative efficacy of topical 10% versus 5% tranexamic acid in treatment of women with melasma: a double-blind randomized controlled trial</dc:title>
<dc:creator xml:lang="en">Mawu, Ferra Olivia</dc:creator>
<dc:creator xml:lang="en">Kapantow, Marlyn Grace</dc:creator>
<dc:creator xml:lang="en">Pandaleke, Herry E. J.</dc:creator>
<dc:creator xml:lang="en">Cahyadi, Alexandro Ivan</dc:creator>
<dc:creator xml:lang="en">Togelang, Lidya</dc:creator>
<dc:creator xml:lang="en">Tampi, Joan Alexandra</dc:creator>
<dc:creator xml:lang="en">Christopher, Paulus Mario</dc:creator>
<dc:subject xml:lang="en">Melasma</dc:subject>
<dc:subject xml:lang="en">topical</dc:subject>
<dc:subject xml:lang="en">tranexamic acid</dc:subject>
<dc:subject xml:lang="en">MASI</dc:subject>
<dc:subject xml:lang="en">pigmentation</dc:subject>
<dc:subject xml:lang="en">women</dc:subject>
<dc:description xml:lang="en">BackgroundMelasma is a highly prevalent chronic pigmentary disorder. The pathogenesis is unknown but melasma often occurs in photo-exposed areas, e.g., cheeks, upper lip, chin, and forehead. Tranexamic acid (TA), a plasmin inhibitor, aids in the inhibition of UV-induced plasmin activity and melanogenesis, making it a favorable therapeutic option for melasma. Tranexamic acid may be administered through various routes, e.g., topical. This study aimed to compare the efficacy of topical 10% versus 5% TA in women with melasma.
MethodsThis double-blind randomized controlled trial included 16 females with epidermal type melasma who were randomized into two groups to receive either topical 10% TA (n = 8) or 5% TA (n = 8) applied twice daily for eight weeks. Prior to intervention and at 8 weeks after intervention, the intensity and extension of melasma were assessed based on melasma area and severity index (MASI) score and pigmentation score.
ResultsMean MASI and pigmentation scores in both treatment groups were similar at base-line (p&gt;0.05). The reduction in MASI and pigmentation scores in the topical 10% TA and 5% TA groups was similar and statistically not significant after 4 and 8 weeks of treatment (p&gt;0.05). There were no drug-related adverse reactions or complications.
ConclusionThis study demonstrated that topical 10% TA and 5% TA were effective in treating women with melasma. The utilization of topical 5% TA for melasma is a promising alternative therapeutic option without the need to increase the concentration of the formulation.</dc:description>
<dc:publisher xml:lang="en">Faculty of Medicine, Universitas Trisakti</dc:publisher>
<dc:date>2024-08-12</dc:date>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
<dc:format>application/pdf</dc:format>
<dc:identifier>https://univmed.org/ejurnal/index.php/medicina/article/view/1549</dc:identifier>
<dc:identifier>10.18051/UnivMed.2024.v43.213-219</dc:identifier>
<dc:source xml:lang="en">Universa Medicina; Vol. 43 No. 2 (2024); 213-219</dc:source>
<dc:source>2407-2230</dc:source>
<dc:source>1907-3062</dc:source>
<dc:source>10.18051/UnivMed.2024.v43.i2</dc:source>
<dc:language>eng</dc:language>
<dc:relation>https://univmed.org/ejurnal/index.php/medicina/article/view/1549/790</dc:relation>
<dc:rights xml:lang="en">Copyright (c) 2024 Ferra Olivia Mawu, Marlyn Grace Kapantow, Herry E. J. Pandaleke, Alexandro Ivan Cahyadi, Lidya Togelang, Joan Alexandra Tampi, Paulus Mario Christopher</dc:rights>
<dc:rights xml:lang="en">https://creativecommons.org/licenses/by-nc-sa/4.0</dc:rights>
</oai_dc:dc>
Sitasi dan pengindeksan
Jumlah menurut tiap indeks pada 13 Nov 2026; setiap indeks menghitung sitasi dengan cara berbeda.
OpenAlex juga mencatat karya ini di: crossref, doaj.
Sitasi artikel ini
APA 7
Mawu, F. O., Kapantow, M. G., Pandaleke, H. E. J., Cahyadi, A. I., Togelang, L., Tampi, J. A., & Christopher, P. M. (2024). Comparative efficacy of topical 10% versus 5% tranexamic acid in treatment of women with melasma: a double-blind randomized controlled trial. Universa Medicina, 43(2), 213–219. https://doi.org/10.18051/UnivMed.2024.v43.213-219
Salin
IEEE
F. O. Mawu, M. G. Kapantow, H. E. J. Pandaleke, A. I. Cahyadi, L. Togelang, J. A. Tampi, and P. M. Christopher, “Comparative efficacy of topical 10% versus 5% tranexamic acid in treatment of women with melasma: a double-blind randomized controlled trial,” Universa Medicina, vol. 43, no. 2, pp. 213–219, 2024, doi: 10.18051/UnivMed.2024.v43.213-219.
Salin
Dibuat dari metadata jurnal; periksa nama penulis sebelum dipakai.